Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Intrauterine Contraceptive Devices Market by Type (Hormonal IUCD, Copper IUCD), By Application (Hospitals, Gynecological Clinics, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Intrauterine Contraceptive Devices Market by Type (Hormonal IUCD, Copper IUCD), By Application (Hospitals, Gynecological Clinics, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 197172 3300 Medical Devices & Consumables 377 233 Pages 4.6 (43)
                                          

The global intrauterine contraceptive devices market is expected to grow at a CAGR of 3.5% during the forecast period, to reach USD 2.2 billion by 2030. The growth of this market is driven by the increasing awareness about contraception and rising demand for long-term contraception methods among women in developing countries. Hormonal IUCDs are expected to dominate the global intrauterine contraceptive devices market during the forecast period, accounting for over 50% share of total revenue in 2018. Hormonal IUCDs are preferred due to their effectiveness and convenience as they can be inserted into uterus without surgery or anesthesia and can be left inside for up to 10 years without any need for removal or replacement. Copper IUCDs are also gaining popularity due to their low cost and ease of use as they do not require any insertion procedure or removal after a certain duration like hormonal IUCDs do.

  1. The IUD market is expected to reach $2,890 million by 2022.
  2. Increasing awareness about the benefits of IUDs and increasing number of women in the reproductive age group are some factors that are driving the growth of this market.
  3. Increasing use of long-acting reversible contraceptives (LARC) such as intrauterine devices (IUDs) and implants for birth control purposes is also driving the growth of this market.
  4. Lack of awareness about side effects associated with intrauterine devices and lack of skilled healthcare professionals in developing countries are some factors that may hamper the growth rate.

Industry Growth Insights published a new data on “Intrauterine Contraceptive Devices Market”. The research report is titled “Intrauterine Contraceptive Devices Market research by Types (Hormonal IUCD, Copper IUCD), By Applications (Hospitals, Gynecological Clinics, Other), By Players/Companies Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network Ltd., Bayer Healthcare Ag (Subsidiary of Bayer Ag), Actavis PLC, Medisafe Distribution Inc., Pace Pharmaceuticals”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Intrauterine Contraceptive Devices Market Research Report

By Type

Hormonal IUCD, Copper IUCD

By Application

Hospitals, Gynecological Clinics, Other

By Companies

Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network Ltd., Bayer Healthcare Ag (Subsidiary of Bayer Ag), Actavis PLC, Medisafe Distribution Inc., Pace Pharmaceuticals

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Intrauterine Contraceptive Devices Industry Outlook


Global Intrauterine Contraceptive Devices Market Report Segments:

The global Intrauterine Contraceptive Devices market is segmented on the basis of:

Types

Hormonal IUCD, Copper IUCD

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Gynecological Clinics, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Teva Pharmaceutical Industries
  2. Medicines360
  3. Trimedic Supply Network Ltd.
  4. Bayer Healthcare Ag (Subsidiary of Bayer Ag)
  5. Actavis PLC
  6. Medisafe Distribution Inc.
  7. Pace Pharmaceuticals

Global Intrauterine Contraceptive Devices Market Overview


Highlights of The Intrauterine Contraceptive Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Hormonal IUCD
    2. Copper IUCD
  1. By Application:

    1. Hospitals
    2. Gynecological Clinics
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Intrauterine Contraceptive Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Intrauterine Contraceptive Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Intrauterine contraceptive devices (IUDs) are a type of birth control that are inserted into the uterus by a doctor. IUDs work by preventing sperm from fertilizing an egg. IUDs can be used for up to 10 years and may also help prevent pelvic inflammatory disease (PID).

Some of the major companies in the intrauterine contraceptive devices market are Teva Pharmaceutical Industries, Medicines360, Trimedic Supply Network Ltd., Bayer Healthcare Ag (Subsidiary of Bayer Ag), Actavis PLC, Medisafe Distribution Inc., Pace Pharmaceuticals.

The intrauterine contraceptive devices market is expected to register a CAGR of 3.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Intrauterine Contraceptive Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Intrauterine Contraceptive Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Intrauterine Contraceptive Devices Market - Supply Chain
   4.5. Global Intrauterine Contraceptive Devices Market Forecast
      4.5.1. Intrauterine Contraceptive Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Intrauterine Contraceptive Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Intrauterine Contraceptive Devices Market Absolute $ Opportunity

5. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
      5.3.1. Hormonal IUCD
      5.3.2. Copper IUCD
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Gynecological Clinics
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Intrauterine Contraceptive Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Intrauterine Contraceptive Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Intrauterine Contraceptive Devices Demand Share Forecast, 2019-2026

9. North America Intrauterine Contraceptive Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Gynecological Clinics
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
      9.7.1. Hormonal IUCD
      9.7.2. Copper IUCD
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Intrauterine Contraceptive Devices Demand Share Forecast, 2019-2026

10. Latin America Intrauterine Contraceptive Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Gynecological Clinics
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
      10.7.1. Hormonal IUCD
      10.7.2. Copper IUCD
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Intrauterine Contraceptive Devices Demand Share Forecast, 2019-2026

11. Europe Intrauterine Contraceptive Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Gynecological Clinics
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
      11.7.1. Hormonal IUCD
      11.7.2. Copper IUCD
   11.8. Basis Point Share (BPS) nalysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Intrauterine Contraceptive Devices Demand Share, 2019-2026

12. Asia Pacific Intrauterine Contraceptive Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Gynecological Clinics
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
      12.7.1. Hormonal IUCD
      12.7.2. Copper IUCD
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Intrauterine Contraceptive Devices Demand Share, 2019-2026

13. Middle East & Africa Intrauterine Contraceptive Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Intrauterine Contraceptive Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Intrauterine Contraceptive Devices Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Gynecological Clinics
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Intrauterine Contraceptive Devices Market Size and Volume Forecast by Type
      13.7.1. Hormonal IUCD
      13.7.2. Copper IUCD
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Intrauterine Contraceptive Devices Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Intrauterine Contraceptive Devices Market: Market Share Analysis
   14.2. Intrauterine Contraceptive Devices Distributors and Customers
   14.3. Intrauterine Contraceptive Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Teva Pharmaceutical Industries
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Medicines360
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Trimedic Supply Network Ltd.
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Bayer Healthcare Ag (Subsidiary of Bayer Ag)
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Actavis PLC
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Medisafe Distribution Inc.
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Pace Pharmaceuticals
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us